Found: 22
Select item for more details and to access through your institution.
International workshop on immune tolerance induction: consensus recommendations.
- Published in:
- 2007
- By:
- Publication type:
- Other
Strategies towards a longer acting factor VIII.
- Published in:
- Haemophilia, 2006, v. 12, p. 42, doi. 10.1111/j.1365-2516.2006.01260.x
- By:
- Publication type:
- Article
Implications of emerging pathogens in the management of haemophilia.
- Published in:
- Haemophilia, 2006, v. 12, p. 1, doi. 10.1111/j.1365-2516.2006.01193.x
- By:
- Publication type:
- Article
The physician's role in selecting a factor replacement therapy.
- Published in:
- Haemophilia, 2006, v. 12, p. 21, doi. 10.1111/j.1365-2516.2006.01197.x
- By:
- Publication type:
- Article
Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
New high-technology products for the treatment of haemophilia.
- Published in:
- Haemophilia, 2004, v. 10, p. 55, doi. 10.1111/j.1365-2516.2004.00996.x
- By:
- Publication type:
- Article
Can we improve on nature?“Super molecules” of factor VIII.
- Published in:
- Haemophilia, 1998, v. 4, n. 4, p. 370, doi. 10.1046/j.1365-2516.1998.440370.x
- By:
- Publication type:
- Article
Bioengineered molecules for the management of haemophilia: Promise and remaining challenges.
- Published in:
- Haemophilia, 2018, v. 24, p. 68, doi. 10.1111/hae.13507
- By:
- Publication type:
- Article
Advantage of recombinant von Willebrand factor for peri‐operative management in paediatric acquired von Willebrand syndrome.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors—A retrospective analysis.
- Published in:
- Haemophilia, 2018, v. 24, n. 2, p. 245, doi. 10.1111/hae.13413
- By:
- Publication type:
- Article
Establishing the appropriate primary endpoint in haemophilia gene therapy pivotal studies.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Evidence-based guidelines support integrated disease management as the optimal model of haemophilia care.
- Published in:
- Haemophilia, 2016, v. 22, p. 3, doi. 10.1111/hae.12997
- By:
- Publication type:
- Article
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.
- Published in:
- Haemophilia, 2016, v. 22, n. 4, p. 514, doi. 10.1111/hae.12905
- By:
- Publication type:
- Article
Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Outcomes of mentored, grant-funded fellowship training in haemostasis /thrombosis: findings from a nested case-control survey study.
- Published in:
- Haemophilia, 2012, v. 18, n. 3, p. 326, doi. 10.1111/j.1365-2516.2011.02626.x
- By:
- Publication type:
- Article
Healthcare resource utilization among haemophilia A patients in the United States.
- Published in:
- Haemophilia, 2012, v. 18, n. 3, p. 332, doi. 10.1111/j.1365-2516.2011.02677.x
- By:
- Publication type:
- Article
Prophylactic therapy with Fibrogammin<sup>®</sup> P is associated with a decreased incidence of bleeding episodes: a retrospective study.
- Published in:
- Haemophilia, 2010, v. 16, n. 2, p. 316, doi. 10.1111/j.1365-2516.2009.02123.x
- By:
- Publication type:
- Article
Functional roles of the factor VIII B domain.
- Published in:
- Haemophilia, 2009, v. 15, n. 6, p. 1187, doi. 10.1111/j.1365-2516.2009.02026.x
- By:
- Publication type:
- Article
Experience with a third generation recombinant factor VIII concentrate (Advate<sup>®</sup>) for immune tolerance induction in patients with haemophilia A.
- Published in:
- Haemophilia, 2009, v. 15, n. 3, p. 718, doi. 10.1111/j.1365-2516.2008.01960.x
- By:
- Publication type:
- Article
Progress in the molecular biology of inherited bleeding disorders.
- Published in:
- Haemophilia, 2008, v. 14, p. 130, doi. 10.1111/j.1365-2516.2008.01718.x
- By:
- Publication type:
- Article
Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.
- Published in:
- Haemophilia, 2008, v. 14, p. 138, doi. 10.1111/j.1365-2516.2008.01730.x
- By:
- Publication type:
- Article
Optimizing outcomes for patients with severe haemophilia A.
- Published in:
- Haemophilia, 2007, v. 13, p. 1, doi. 10.1111/j.1365-2516.2007.01552.x
- By:
- Publication type:
- Article